Startup CoraVie Medical aims to give patients and their physicians better control over hypertension with a tiny implantable device. Aimee Garza wants to do for high blood pressure what continuous glucose monitors are doing for diabetes. The veteran medtech engineer and marketing maven brings 25 years of experience at two of medtech’s biggest companies — […]
integer
Integer wins appeal in patent dispute with AVX
An appeals court has upheld a $22.2 million jury verdict in a long-standing patent spat between Integer Holdings (NYSE:ITGR), formerly known as Greatbatch, and AVX, now part of Kyocera. In a ruling released today, a three-judge panel of the U.S. Court of Appeals agreed with a lower court decision that AVX intentionally infringed certain Integer patents with its Ingenio […]
Integer beats The Street on Q1 results, expects temporary COVID-19 sales hit
Integer Holdings (NYSE:ITGR) shares are up slightly today after the company posted Street-beating first-quarter results the previous evening. The Plano, Texas–based medical device contract manufacturing giant reported profits of $31 million, or 29¢ per share, off sales of $328 million for the quarter ended April 3, 2020, for a bottom-line gain of 46% off 4% sales […]
UPDATE: Medtech contract manufacturers make it work during a pandemic
From coping with wild fluctuations in demand to keeping workers safe and customers satisfied, these medical device industry suppliers have managed to adapt amid COVID-19 and an uncharted business environment. Medical device contract manufacturers are finding ways to keep business going during the coronavirus pandemic. Medical Design & Outsourcing recently conducted another round of an informal survey of […]
How medtech contract manufacturers are managing during the coronavirus pandemic
From invoking their business continuity plans to marshaling their pandemic teams, medical device contract manufacturers are finding ways to keep business going during the coronavirus pandemic. Medical Design & Outsourcing conducted an informal survey of manufacturers and other companies that serve the medtech industry. Here’s some of what we learned. Get the full story on our […]
Integer shares up after Street-beating Q4
Integer Holdings (NYSE:ITGR) shares were up at close today on fourth-quarter results that topped the consensus forecast, despite a big dip in profits. The Plano, Texas-based company posted profits of $11 million, or 33¢ per share, on sales of $325.6 million for the three months ended Dec. 31, 2019, for a 57.2% bottom-line slide on sales […]
Integer expands to Israel
Integer Holdings (NYSE:ITGR) today announced it has acquired medtech manufacturer Inomec, formally establishing its presence in Israel. The Plano, Texas-based company said the acquisition will enable it to create an R&D and sales center in the region and adds important catheter design, clinical and pilot manufacturing capabilities to its portfolio. “Acquiring Inomec strengthens our research and development […]
Integer lowers sales, earnings guidance after Nuvectra files for Chapter 11
Integer Holdings (NYSE:ITGR) said today that it has scaled back some guidance for fiscal 2019 among other changes after the announcement that Nuvectra (NSDQ:NVTR) filed for Chapter 11 protection last week. Plano, Texas-based Integer was near the top of the list among creditors with unsecured claims in the filing. The contract manufacturer, listed as Greatbatch Medical, is […]
Integer bests Q3 earnings forecast despite plunging profits
Integer Holdings (NYSE:ITGR) today reported third-quarter earnings that beat the consensus forecast, despite a bottom-line slide of some -73%, and raised its earnings outlook for the rest of the year. The Plano, Texas-based medical device contract manufacturer said profits were down -73.2% to $30.6 million, or 92¢ per share, on a -0.5% top-line slip to $303.6 […]
Integer narrows outlook on fiscal year change
Integer (NYSE:ITGR) this week changed its fiscal year to correspond with the calendar year, prompting it to guide toward the low end of its sales outlook for 2019. The change to calendar-year accounting from a 52/53-week fiscal year means two less business days this year. Get the full story at our sister site, Drug Delivery Business […]
Integer adds US BioDesign’s braided biomedical biz for $15m
Integer (NYSE:ITGR) said yesterday that it acquired US BioDesign‘s braided biomedical business for a minimum of $15 million. The Quakertown, Pa.–based operation makes complex braided and formed biomedical structures for the cardiovascular, neurovascular and general surgery markets. The company also offers product development, materials testing and post-processing services including electropolishing and packaging. The deal calls for […]
